patent for semaglutide Novo Nordisk expiry opens door to cheaper weight-loss drugs in India Day 1, semaglutide patent expiry:

Much of what is labeled lean mass loss reflects changes in water, glycogen, liver mass, and intramuscular fat rather than contractile muscle

This represents one of the broader geographic footprints among 503A compounders in this series, though it falls short of the full 50-state coverage offered by larger national operations

Young men who fasted for 16 hours showed fat loss while maintaining muscle mass

AP correspondent Marcela Sanchez reports on how states are dealing with the high costs of weight loss drugs and the impact limited coverage would have on patients

Some companies are planning to implement it

In this study, we used bioinformatic network analyses to (i) investigate cardioprotective pathways of GLP1RAs through interaction networks and metabolic data, and (ii) assess their combinations with SGLT2i and metformin to explore CV effects beyond glycemic control, (iii) investigate interactors that could play a role in longevity-relevant and major known signaling pathways